The Bengaluru-based start-up Cardiotrack, which provides predictive diagnosis for cardiovascular diseases, has expanded its operations to North America. The IoT Internet of Things (IoT) and Artificial Intelligence (AI) embedded platform in the cardiac space has collaborated with the state of Nuevo Leon, Mexico, to set up its operations and transform people’s lives through their breakthrough diagnostic products.
 
A Letter of Intent (LoI) to this effect was signed with the Governor of Nuevo Leon, Jaime Heliodoro Rodríguez. Cardiotrack will set up operations in Nuevo Leon’s capital, Monterrey and also invest in a unit to train people. This collaboration will create close to 200 jobs in Nuevo Leon.
 
Cardiotrack was founded by industry veterans Ashim Roy and Avin Agrawal. Cardiotrack platform is designed to fulfill the basic requirements of primary healthcare centres (PHC). Here in the absence of a cardiologist, the device diagnoses and captures heart health data of the patients. The IoT and AI embedded device enables instantaneous cardiac monitoring and flow of information through Android-based smart devices between  a physician and a cardiologist. It enables  primary healthcare specialists  in rural and semi-urban areas to detect early signs of cardiovascular disease.
 
The diagnostics sensors used in Cardiotrack function at extreme temperatures, and dust ridden and humid environments. Cardiotrack tele-intervention platform is built to overcome limited availability of specialists, lack of transportation infrastructure and power breakdowns that are common constraints in emerging economies and provide effortless remote patient management and disease care.
 
“We are pleased to have partnered with the Governor of Nuevo Leon. Our focus is primary care and improving the quality of the diagnostics available at PHCs. We  have an  in-depth knowledge of challenges faced by doctors and patients at the PHC.  We  can make a huge difference to the lives of people, not just in India but across the globe. This partnership is one such step towards making healthcare accessible and affordable to all”, said Roy.
 
“Cardiotrack is revolutionising the way cardiovascular diseases are diagnosed. A major reason for getting traction in the market has been affordability, ease of use, device mobility and data portability that the product renders to its users. Most of the health diagnostics products are not only expensive, but can only be operated in hospital environments and do not have any capability to share ECG scan with a cardiologist who may be hundreds of miles away. Cardiotrack addresses this major challenge that exists in the ecosystem by providing a technologically advanced and a cost effective product, said   Agarwal,.
 
Cardiotrack platform includes multi-parameter, light weight healthcare IoT devices and mobile health software that helps to screen illnesses such as cardiovascular diseases and hypertension and helps doctors to perform diagnosis and then safely store the patient records.
 
The Cardiotrack device was launched in September 2015 and approximately 200 of these devices have been deployed across India, Myanmar, Indonesia, Mexico and US.